| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 10/14/2004 | WO2004067550A3 Novel use of mifepristone and derivatives thereof as hedgehog protein signalling pathway modulators and applications of same |
| 10/14/2004 | WO2004000785A3 Phenyloxyalkanonic acid derivatives as hppar activators |
| 10/14/2004 | WO2004000781A3 Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 10/14/2004 | WO2004000762A3 Propionic acid derivatives and their use as hppars activators |
| 10/14/2004 | WO2003075945A3 Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis |
| 10/14/2004 | US20040204673 Modular infusion device and method |
| 10/14/2004 | US20040204596 preventing or treating degradation of collagen, degradation of collagen by bacterial collagenases during a bacterial infection, regeneration of skin and ligaments, tumoral invasion and degenerative diseases having fibrinoid degeneration of collagen |
| 10/14/2004 | US20040204594 S-(+)-4-Methoxy-6-phenethyl-5,6-dihydro-pyran-2-one; plant extracts for nutraceutical foods, topical ointments |
| 10/14/2004 | US20040204590 Ep4 receptor agonist, compositions and methods thereof |
| 10/14/2004 | US20040204588 aryl hydrocarbon; oxidation of 4,5-dihydro-1,3-azoles to fully unsaturated ring; heterocyclic ketones |
| 10/14/2004 | US20040204582 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 10/14/2004 | US20040204500 Preventives/remedies for organ functional disorders and organ dysfunction |
| 10/14/2004 | US20040204487 Novel medicinal product |
| 10/14/2004 | US20040204467 Use of 5HT3-receptor-antagonists |
| 10/14/2004 | US20040204465 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 10/14/2004 | US20040204464 Isoxazoline compounds having MIF antagonist activity |
| 10/14/2004 | US20040204462 E.g., l2-{3-[2-(4-Fluorophenyl)oxazol-4-ylmethoxy]cyclohexyloxy}-6-methylbenzoic acid; lipid- and/or triglyceride-lowering properties; metabolic disorders; antidiabetic agents (type II); therapy of syndrome X; eating disorders; cardiomyopathy |
| 10/14/2004 | US20040204456 Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate |
| 10/14/2004 | US20040204449 New isoquinoline compounds |
| 10/14/2004 | US20040204447 Isoquinolinone derivatives and their use as therapeutic agents |
| 10/14/2004 | US20040204437 Substituted arylamine derivatives and methods of use |
| 10/14/2004 | US20040204431 For therapy cardiovascular disease |
| 10/14/2004 | US20040204416 Pharmaceutical composition for the treatment of CNS and other disorders |
| 10/14/2004 | US20040204408 Piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity |
| 10/14/2004 | US20040204391 Applying onto healed wound a composition comprising a fluid, film-forming carrier, and subsequently hardening the carrier into a tangible membrane juxtaposed to the healed wound thereby reducing scarring or improving the appearance thereof |
| 10/14/2004 | US20040204385 increasing the copper levels in an animal by the administration of a composition containing copper dextran in a dose in a manner selected from parenterally; intramuscularly; and a combination thereof |
| 10/14/2004 | US20040204338 Acetyl-coenzyme a carboxylase 2 as a target in the regulation of fat burning, fat accumulation, energy homeostasis and insulin action |
| 10/14/2004 | US20040204257 System for and a method of manufacturing personal golf putters |
| 10/14/2004 | US20040203118 Polynucleotides and polypeptides of the IFNalpha-14 gene |
| 10/14/2004 | US20040203099 Conjugate of a transport protein and a protein for modulation of notch signalling |
| 10/14/2004 | US20040203097 Kinases and phosphatases |
| 10/14/2004 | US20040203087 screening gene expression inhibition via incubating mrna, determining expression in presence of test compound, then comparing levels; gene knockout |
| 10/14/2004 | US20040203014 Neurotransmisson-associated proteins |
| 10/14/2004 | US20040202736 Method of ameliorating side-effects of SERMs |
| 10/14/2004 | US20040202718 compressible controlled release core, swellable polymers one of which is anionic, and an excipient(s) that improves compressibility; an immediate release composition comprising long-acting sulfonyl urea (glimepiride) and controlled release composition comprising biguanide (metformin) |
| 10/14/2004 | US20040202702 Method and composition for the treatment of scars |
| 10/14/2004 | US20040202671 helminths obtained from preparatory animals raised in a specific human pathogen-free environment used to treat an excessive immune response including an aberrant/enhanced Th1 response, e.g., Crohn's disease and ulcerative colitis |
| 10/14/2004 | CA2521229A1 Improved dietary fiber containing materials comprising low molecular weight glucan |
| 10/14/2004 | CA2521056A1 Hydrazone derivative |
| 10/14/2004 | CA2520689A1 Novel diphenyl azetidinone with improved physiological characteristics, corresponding production method, medicaments containing said compound and use of the latter |
| 10/14/2004 | CA2520375A1 Anti-obesity agent |
| 10/14/2004 | CA2519939A1 Bicyclic piperidine derivatives as melanocortin-4 receptor agonists |
| 10/14/2004 | CA2518913A1 Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof |
| 10/13/2004 | EP1466925A1 Antibodies against fibroblast growth factor 23 |
| 10/13/2004 | EP1466911A2 Preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 10/13/2004 | EP1466909A1 Halogenobenzyl aminopropionic acid derivatives |
| 10/13/2004 | EP1466904A1 Biaryl compound and use thereof |
| 10/13/2004 | EP1466901A1 Serotonine reuptake inhibitor |
| 10/13/2004 | EP1466900A1 2-substituted vitamin d derivatives |
| 10/13/2004 | EP1466891A1 Carboxylic acid derivative |
| 10/13/2004 | EP1466889A1 Derivatives of venlafaxine and methods of preparing and using the same |
| 10/13/2004 | EP1466888A1 Calcium receptor-active arylalkyl amines |
| 10/13/2004 | EP1466632A1 Implantable pouch seeded with insulin-producing cells to treat diabetes |
| 10/13/2004 | EP1466621A1 Compositions for improving lipid metabolism |
| 10/13/2004 | EP1466613A1 Compositions for mucosal and oral administration comprising hCG fragments |
| 10/13/2004 | EP1466604A1 Isoquinoline derivatives, process for their preparation and use thereof in the treatment of melatoninergic system problems |
| 10/13/2004 | EP1466009A2 Highly sensitive and continuous protein-tyrosine-phosphatase (ptpase) test using 6.8 difluoro-4-methyl-umbelliferylphosphate |
| 10/13/2004 | EP1465997A2 Use of biomolecular targets in the treatment and visualization of tumors |
| 10/13/2004 | EP1465924A2 Modulators of notch ic protease activity for use in immunotherapy |
| 10/13/2004 | EP1465911A2 Compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemia |
| 10/13/2004 | EP1465891A2 Inhibitors of dipeptidyl peptidase iv |
| 10/13/2004 | EP1465889A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 10/13/2004 | EP1465888A2 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues |
| 10/13/2004 | EP1465885A2 Novel alkyl/aryl hydroxy or keto thiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake |
| 10/13/2004 | EP1465880A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine |
| 10/13/2004 | EP1465872A1 4-sulfide/sulfoxide/sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor |
| 10/13/2004 | EP1465871A1 Pyrazole derivatives for use in diseases associated with the 5-ht2c receptor |
| 10/13/2004 | EP1465870A2 Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the same |
| 10/13/2004 | EP1465869A1 Modulators of lxr |
| 10/13/2004 | EP1465867A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 10/13/2004 | EP1465865A2 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 10/13/2004 | EP1465864A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 10/13/2004 | EP1465863A1 Potassium channel modulators |
| 10/13/2004 | EP1465858A2 Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity |
| 10/13/2004 | EP1465854A2 Chalcone derivatives and their use to treat diseases |
| 10/13/2004 | EP1465667A2 Screening and selection methods for statin drug combinations |
| 10/13/2004 | EP1465649A2 Methods and compositions for derepression of iap-inhibited caspase |
| 10/13/2004 | EP1465641A1 Pharmaceutical and foodstuff products comprising deuterium for the treatment of diabetes and methods for production thereof |
| 10/13/2004 | EP1465638A2 Phosphate transport inhibitors |
| 10/13/2004 | EP1465637A1 25-hydroxy vitamin d3 compositions |
| 10/13/2004 | EP1465635A2 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues |
| 10/13/2004 | EP1465631A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 10/13/2004 | EP1465630A1 Cyclic urea derivatives with 5-ht2c receptor activity |
| 10/13/2004 | EP1465628A2 Fine particle size pioglitazone |
| 10/13/2004 | EP1465627A1 DOSING REGIMEN FOR PPAR−GAMMA ACTIVATORS |
| 10/13/2004 | EP1465622A1 Use of ppar activators for the treatment of pulmonary fibrosis |
| 10/13/2004 | EP1465619A1 Suppression of cartilage degradation via the estrogen receptor |
| 10/13/2004 | EP1465616A1 Treatment of statin side effects using uridine derivatives |
| 10/13/2004 | EP1465613A2 Combination of mtp inhibitors or apob secretion inhibitors with fibrates for use as drugs |
| 10/13/2004 | EP1465605A1 Pravastatin pharmaceutical formulations and methods of their use |
| 10/13/2004 | EP1465521A2 System and method for the pretreatment of the endplates of an intervertebral disc |
| 10/13/2004 | EP1465504A1 Matrix-forming composition containing pectin |
| 10/13/2004 | EP1465493A1 Cultured and encapsulated pancreatic stem cells |
| 10/13/2004 | EP1397137A4 Hydantion derivatives as inhibitors of matrix metalloproteinases |
| 10/13/2004 | EP1381615B1 ANTIDEPRESSANT INDOLETETRAHYDROPYRIDINE DERIVATIVES OF 2,3-DIHYDRO-7H- [1,4]DIOXINO[2,3-e]INDOLE |
| 10/13/2004 | EP1381613B1 Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused-(1,4)-benzodioxans |
| 10/13/2004 | EP1347987B1 Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
| 10/13/2004 | EP1322309A4 High affinity small molecule c5a receptor modulators |
| 10/13/2004 | EP1280797B1 Inhibitors of dipeptidyl peptidase iv |
| 10/13/2004 | EP1202965B1 Indole derivatives, processes for their preparation, pharmaceutical compositions containing them and their medicinal application |